» Articles » PMID: 17802917

Analysis of HIV-1 Drug-resistant Variants in Plasma and Peripheral Blood Mononuclear Cells from Untreated Individuals: Implications for Clinical Management

Overview
Journal New Microbiol
Specialty Microbiology
Date 2007 Sep 7
PMID 17802917
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Genotypic resistance analysis on viral DNA and plasma was performed in 56 therapy naive patients with recent and chronic infection to assess the prevalence of mutations associated with drug resistance and compare cell-free and cell-associated strains. Direct sequencing of DNA provirus disclosed key mutations to RT inhibitors more frequently than in plasma RNA. In addition, major mutations associated with drug resistance in the PR region were only found in PBMCs. Although our data are limited to a small cohort, they show a different resistance profile between plasma and PBMC compartments and may yield additional information for first-line antiretroviral regimens.

Citing Articles

Consistency of drug-resistant mutations in plasma and peripheral blood mononuclear cells of patients with treatment-naïve and treatment-experienced HIV-1 infection.

Ma J, Chen Z, Fu C, Wei S, Liu J, Yang X Front Cell Infect Microbiol. 2024; 13:1249837.

PMID: 38179423 PMC: 10766352. DOI: 10.3389/fcimb.2023.1249837.


HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing.

Curanovic D, Martens S, Rodriguez M, Hammill H, Petropoulos C, Walworth C Open Forum Infect Dis. 2023; 10(4):ofad146.

PMID: 37065991 PMC: 10096913. DOI: 10.1093/ofid/ofad146.


HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads.

Bareng O, Choga W, Maphorisa S, Seselamarumo S, Seatla K, Mokgethi P Infect Drug Resist. 2022; 15:7565-7576.

PMID: 36582452 PMC: 9792565. DOI: 10.2147/IDR.S388816.


HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.

Bareng O, Moyo S, Zahralban-Steele M, Maruapula D, Ditlhako T, Mokaleng B J Antimicrob Chemother. 2022; 77(5):1385-1395.

PMID: 35229102 PMC: 9633723. DOI: 10.1093/jac/dkac056.


Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.

Moyo S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, Nkhisang T, Mokaleng B AIDS. 2019; 33(6):1073-1082.

PMID: 30946161 PMC: 6467559. DOI: 10.1097/QAD.0000000000002166.